UASt regulatory sequences drive expression of an inverted repeat.
Expression of AdamTS-BKK108644 under the control of Scer\GAL4Bx-MS1096 leads to either an extra branch on the posterior crossvein (PCV) or a delta at the PCV compared to controls.
Expression of CG4096KK108644 under the control of Scer\GAL4Act5C.PU results in an extra vein phenotype with an additional vin fragment above vein L2 and some vein deltas and a reduction in wing size.
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, suppressible by Ras85De1B
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, suppressible | partially by spi1/Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, suppressible | partially by vnL6/Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, suppressible by spi1/vnL6/Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, non-suppressible by Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, non-suppressible by spi1/vnL6
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, non-suppressible by Df(2R)Egfr3
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, non-suppressible by pntΔ88
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, non-suppressible by spi1
AdamTS-BKK108644, Scer\GAL4Act5C.PU has visible phenotype, non-suppressible by vnddd-3
Scer\GAL4Act5C.PU/AdamTS-BKK108644 is an enhancer of visible phenotype of EgfrE1
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, suppressible by Ras85De1B
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, suppressible | partially by spi1/Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, suppressible | partially by vnL6/Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, suppressible by spi1/vnL6/Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, non-suppressible by Df(2R)Egfr3
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, non-suppressible by pntΔ88
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, non-suppressible by spi1
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, non-suppressible by vnddd-3
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, non-suppressible by Krn27
AdamTS-BKK108644, Scer\GAL4Act5C.PU has wing vein | ectopic phenotype, non-suppressible by spi1/vnL6
Scer\GAL4Act5C.PU/AdamTS-BKK108644 is an enhancer of wing vein | ectopic phenotype of EgfrE1
Expression of CG4096KK108644 under the control of Scer\GAL4Act5C.PU enhances the extra wing vein phenotype of EgfrE1 flies.
The extra wing vein phenotype caused by expression of CG4096KK108644 under the control of Scer\GAL4Act5C.PU is not suppressed if the flies also carry one of Df(2R)Egfr3, pntΔ88, spi1, vnddd-3 or Krn27.
The extra wing vein phenotype caused by expression of CG4096KK108644 under the control of Scer\GAL4Act5C.PU is not suppressed if the flies also simultaneously carry vnL6 and spi1.
The extra wing vein phenotype caused by expression of CG4096KK108644 under the control of Scer\GAL4Act5C.PU is significantly suppressed if the flies also carry Ras85De1B.
The extra wing vein phenotype caused by expression of CG4096KK108644 under the control of Scer\GAL4Act5C.PU is significantly suppressed if the also simultaneously carry both spi1 and Krn27, or both vnL6 and Krn27. The suppression is more pronounced if the flies simultaneously carry spi1, Krn27 and vnL6.